Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis

Hepatology - United States
doi 10.1002/hep.28932
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

New Developments in the Treatment of Primary Biliary Cholangitis &Ndash; Role of Obeticholic Acid

Therapeutics and Clinical Risk Management
2017English

Cost Effectiveness of Using Ursodeoxycholic Acid to Treat Primary Biliary Cholangitis

British journal of hospital medicine (London, England : 2005)
Medicine
2018English

Biochemical and Histological Effectiveness of Long-Term Use of Fenofibrate for Asymptomatic Primary Biliary Cholangitis

Journal of Gastroenterology and Hepatology Research
HepatologyGastroenterology
2016English

Primary Biliary Cholangitis: From Diagnosis to Treatment

Annals of Gastroenterology and the Digestive System
2018English

Primary Biliary Cholangitis: An Update on Treatment

Gastrointestinal Nursing
Surgical NursingMedicalSpecialized NursingAdvanced
2019English

Letter: Long-Term Treatment of Severe Bile Acid Diarrhoea-Obeticholic Acid Can Normalise SeHCAT Retention. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Changing Nomenclature for PBC From “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

Journal of Gastroenterology
Gastroenterology
2016English

The British Society of Gastroenterology/Uk-PBC Primary Biliary Cholangitis Treatment and Management Guidelines

Gut
Gastroenterology
2018English

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy